Search Results - "Domanský, Jiří"

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
  2. 2
  3. 3

    Genomic DNA-based measurable residual disease monitoring in pediatric acute myeloid leukemia: unselected consecutive cohort study by Zaliova, Marketa, Zuna, Jan, Winkowska, Lucie, Janotova, Iveta, Skorepova, Justina, Lukes, Julius, Meyer, Claus, Marschalek, Rolf, Novak, Zbynek, Domansky, Jiri, Stary, Jan, Sramkova, Lucie, Trka, Jan

    Published in Leukemia (01-01-2024)
    “…Measurable residual disease (MRD) monitoring in childhood acute myeloid leukemia (AML) is used to assess response to treatment and for early detection of…”
    Get full text
    Journal Article
  4. 4

    Independent Prognostic Value of DNA-Based Minimal Residual Disease Assessment in Unselected Population-Based Cohort of Pediatric Acute Myeloid Leukemia by Zaliova, Marketa, Zuna, Jan, Winkowska, Lucie, Janotova, Iveta, Skorepova, Justina, Lukes, Julius, Meyer, Claus, Marschalek, Rolf, Domansky, Jiri, Novak, Zbynek, Stary, Jan, Sramkova, Lucie, Trka, Jan

    Published in Blood (02-11-2023)
    “…Monitoring of minimal residual disease (MRD) in childhood acute myeloid leukemia (AML) can assess response to treatment and predict relapse. Current MRD…”
    Get full text
    Journal Article
  5. 5

    Acute Bilineal Leukemia Is a Very Rare Entity in Childhood by Mejstrikova, Ester, Slamova, Lucie, Fronkova, Eva, Volejnikova, Jana, Muzikova, Katerina, Domansky, Jiri, Sterba, Jaroslav, Zapletal, Ondrej, Zemanova, Zuzana, Lizcova, Libuse, Vodickova, Elena, Zuna, Jan, Trka, Jan, Stary, Jan, Hrusak, Ondrej

    Published in Blood (18-11-2011)
    “…Abstract 4871 Recent WHO 2008 classification introduced a new category named Mixed Phenotype Acute Leukemia (MPAL) for leukemias in which primary lineage…”
    Get full text
    Journal Article